top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
The Trump administration reclassified FDA-approved and state-licensed medical marijuana products as Schedule III substances and scheduled a June 2026 hearing to expedite broader rescheduling. This policy shift currently excludes adult-use cannabis businesses, which remain federally illegal and do not receive immediate tax or banking relief.

The Feds are officially reclassifying medical herb as a Schedule III substance.

Apr 23, 2026

Source:

Noel Abbott

Ganjapreneur

Big news is coming out of Washington that has the entire cannabis community buzzing. In a historic move, the federal government has officially reclassified medical marijuana from Schedule I to Schedule III. This means that for the first time in over fifty years, the Department of Justice is acknowledging what we have known all along: this plant has legitimate medicinal value.

So, what does this actually look like on the ground? For now, the shift applies specifically to products approved by the FDA and those sold within state-licensed medical programs. By moving into the same category as substances like ketamine or Tylenol with codeine, medical cannabis businesses can finally breathe a sigh of relief. This change effectively removes the heavy tax burdens that have hindered local dispensaries, allowing them to reinvest in better quality flower and improved patient services.

While this is a massive win for medical patients and researchers, it’s important to note that adult-use or recreational markets aren't seeing the same immediate benefits just yet. Those shops are still navigating the old rules for the time being, meaning banking and tax relief haven't quite reached them. However, the momentum is undeniable. The administration has already set a date for late June 2026 to start a new, faster process to decide if all cannabis should be moved out of the most restrictive federal category.

For the everyday enthusiast, this represents a huge cultural shift. We are moving away from the "reefer madness" era and toward a future where science and common sense lead the way. It means more transparent research into the strains we love and a more stable industry for the people who grow them. If you are a medical cardholder, keep an eye on your local shop—these changes should eventually lead to a wider variety of tested, high-quality products. It’s a great time to be part of this community as we watch the walls of prohibition finally start to crumble.

Recent Reviews

bottom of page